Key laboratory indicators for both disorders include significantly elevated LDH, severe thrombocytopenia, declining Hgb, and the presence of schistocytes, with ADAMTS13 activity of <10% being specific to aTTP. This evidence concerns the gene ADAMTS13 and Thrombocytopenia.